StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Amgen chairman and CEO Robert A. Bradway Amgen (AMGN) signaled it intends to become the third powerhouse developer in the...
Home » Biotech Advances
Amgen chairman and CEO Robert A. Bradway Amgen (AMGN) signaled it intends to become the third powerhouse developer in the...
BioSolution Designs (BSD) reported that it is collaborating with RoosterBio to simplify the development and manufacturing of engineered human mesenchymal...
REGISTER NOW Broadcast Date: Thursday, May 16, 2024Time: 8:00 am PDT, 11:00 am EDT, 17:00 CEST Altered dopaminergic neurotransmission underlies...
Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can...
REGISTER NOW Broadcast Date: Thursday, June 13, 2024Time: 8:00 am PDT, 11:00 am EDT, 17:00 CEST Studying the spatial organization...
Antibodies perform like guided missiles, inspiring therapeutic developers to produce their own antibody-based weapons systems. Whereas natural antibodies have structures...
/*! elementor - v3.21.0 - 30-04-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} A modern-day red squirrel in the British Isles...
On last month’s episode of our monthly science talk show GEN Live—“Is Gene Therapy Nearing a Tipping Point?”—I was joined...
Despite being one of the most common and well-known neurodegenerative diseases, multiple sclerosis (MS) remains difficult to treat. However, new...
Moonwalk Biosciences launched earlier this year, crashing the epigenome editing bash. So it is not surprising that the companys name...
Explore the synergy of chemistry and technology with ChemTech Digest. Dive into the latest research, tech advancements, and scientific discoveries shaping our world.
Copyright 2024 © All Rights Reserved. ChemTech Digest | SiteMap